Imaging in Pediatric Oncology: New Advances and Techniques
The discovery of X-rays by Wilhelm Röntgen in 1895 was translated with remarkable speed into routine clinical practice. Since that time there has been an astonishing expansion in the range and medical use of imaging technologies. The current wide array of available imaging options makes the choice of modality of crucial importance, and, within the field of pediatric oncology, this requires an understanding of likely diagnoses, disease-specific tumor evaluation and staging methods, treatment protocols, and associated potential complications and long-term toxicities. Radiologists therefore have a crucial role within the multidisciplinary team that cares for these complex patients.
KeywordsStaging Toxicity Treatment protocol Multidisciplinary team Interventional Ultrasound Computerized tomography Magnetic resonance imaging Positron emission tomography Nuclear medicine
- 1.Sweet E. Paediatric radiology in Great Britain and Ireland. In: Kaufmann HJ, Ringertz H, Sweet E, editors. The first 30 years of the ESPR. Berlin: Springer; 1993. p. 1–2.Google Scholar
- 7.Matthay KK, Shulkin B, Ladenstein R, Michon J, Giammarile F, Lewington V, et al. Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force. Br J Cancer. 2010;102(9):1319–26.CrossRefGoogle Scholar
- 10.Grundy PE, Green DM, Dirks AC, Berendt AE, Breslow NE, Anderson JR, et al. Clinical significance of pulmonary nodules detected by CT and Not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and -5: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2012;59(4):631–5.CrossRefGoogle Scholar
- 20.Furth C, Steffen IG, Amthauer H, Ruf J, Misch D, Schönberger S, et al. Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin’s lymphoma: analysis of a prospective multicenter trial. J Clin Oncol. 2009;27(26):4385–91.CrossRefGoogle Scholar